Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Phase II Dose-response Pilot Study of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Anxiety Associated With Advanced-stage Cancer.


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00252174

Organisation Name: Brigham and Women's Hospital

Overal Status: Terminated

Start Date: February 2007

Last Update: November 14, 2017

Lead Sponsor: Brigham and Women's Hospital

Brief Summary: This is a pilot study intended to find out if 3,4-methylenedioxymethamphetamine (MDMA) is safe and can help people with advanced stage cancer and anxiety arising from the cancer diagnosis.

Conditions:
  • Anxiety Disorder
  • Cancer


Total execution time in seconds: 0.17728900909424